Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€19.92
28.09.21
-
28.09.22
-6.85%
02.10.21

Could be worthwhile Investment >10% per year
Vassago1 
28.09.21 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.79
20.09.21
-
20.09.25
-26.16%
03.04.23

Could be worthwhile Investment >10% per year
Lutz69 
20.09.21 50%
buy
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€14.20
18.09.21
€40.00
31.12.23
61.97%
16.12.21

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
18.09.21 70%
buy
ESSA Pharma Inc

Start price
Target price
Perf. (%)
€6.85
16.08.21
-
16.08.22
-0.73%
22.08.21

Risky Investment
blaugold 
16.08.21 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€9.95
05.08.21
-
05.08.22
23.44%
08.08.21

Could be worthwhile Investment >10% per year
Vassago1 
05.08.21 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.39
08.07.21
-
08.07.22
13.98%
08.07.22

Joe130978 
08.07.21 50%
buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€3.22
11.06.21
€4.00
11.06.22
-69.57%
14.12.21

Could be worthwhile Investment >10% per year
melinda 
11.06.21 50%
buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€4.64
01.05.21
€4.50
01.05.22
-30.60%
11.06.21

Could be worthwhile Investment >10% per year
melinda 
01.05.21 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€16.47
19.03.21
€13.00
19.03.22
-22.87%
20.02.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
19.03.21 60%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€13.38
08.03.21
€15.00
13.62%
10.03.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
08.03.21 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€20.95
10.02.21
€22.00
11.75%
11.02.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
10.02.21 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€36.00
07.02.21
-
07.02.22
-80.67%
08.02.22

Probably not worthwhile Investment
High risks for its business
Few uniques
Trip 
07.02.21 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€9.43
14.01.21
€28.00
72.92%
12.03.21

Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
gerihouse 
14.01.21 70%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€7.48
11.01.21
-
11.01.22
39.14%
15.01.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
11.01.21 70%
buy
Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€60.55
16.11.20
€105.00
16.11.21
-10.40%
28.11.20

Could be worthwhile Investment >10% per year
Good rating
Differentiated customer and product portfolio
Risky balance sheet
me8 
16.11.20 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€4.90
14.11.20
-
14.11.21
23.24%
27.11.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
14.11.20 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€5.20
07.11.20
€6.40
23.49%
30.11.20

Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
gerihouse 
07.11.20 50%
sell
Aphria Inc.

Start price
Target price
Perf. (%)
€4.70
05.11.20
-
05.11.21
170.32%
06.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
shadow 
05.11.20 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€3.92
31.10.20
-
04.11.21
20.56%
09.11.20

DrMabuse 
31.10.20 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€16.60
31.10.20
-
04.11.21
24.82%
09.11.20

DrMabuse 
31.10.20 50%
sell
Trillium Therapeutics

Start price
Target price
Perf. (%)
€8.28
07.09.20
-
04.11.21
-21.91%
15.07.21

Could be very worthwhile Investment >20% year
Biotechhunter 
07.09.20 50%
buy
Trillium Therapeutics

Start price
Target price
Perf. (%)
€8.76
22.08.20
-
07.09.20
-5.48%
07.09.20

Could be very worthwhile Investment >20% year
Biotechhunter 
22.08.20 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€4.27
14.07.20
€5.85
05.08.20
-5.09%
05.08.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
14.07.20 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€3.70
24.05.20
€5.00
26.06.20
-0.54%
26.06.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
24.05.20 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.08
20.05.20
€4.50
04.11.21
56.99%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
20.05.20 50%